Antidepressant treatment and emotional processing: can we dissociate the roles of serotonin and noradrenaline?
The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Abstract
The ability to match individual patients to tailored treatments has the potential to greatly improve outcomes for individuals suffering from major depression. In particular, while the vast majority of antidepressant treatments affect either serotonin or noradrenaline or a combination of these two neurotransmitters, it is not known whether there are particular patients or symptom profiles which respond preferentially to the potentiation of serotonin over noradrenaline or vice versa. Experimental medicine models suggest that the primary mode of action of these treatments may be to remediate negative biases in emotional processing. Such models may provide a useful framework for interrogating the specific actions of antidepressants. Here, we therefore review evidence from studies examining the effects of drugs which potentiate serotonin, noradrenaline or a combination of both neurotransmitters on emotional processing. These results suggest that antidepressants targeting serotonin and noradrenaline may have some specific actions on emotion and reward processing which could be used to improve tailoring of treatment or to understand the effects of dual-reuptake inhibition. Specifically, serotonin may be particularly important in alleviating distress symptoms, while noradrenaline may be especially relevant to anhedonia. The data reviewed here also suggest that noradrenergic-based treatments may have earlier effects on emotional memory that those which affect serotonin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and in particular, that drugs which potentiate noradrenaline may have more prominent effects in upregulating positive aspects of emotional processing.80”
From The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment (2015) · cites this paper as [80]
In the citing paper
“Preliminary evidence from existing data on the effects of drugs which primarily potentiate NA and those that primarily potentiate 5-HT suggest that broad patterns of effects in emotional processing may be associated with these two different classes of drugs”
From The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment (2015) · cites this paper as [80]
Citations
Cites
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Cognitive Therapy for Depression: (675542012-001)
(2012) · PsycEXTRA Dataset · doi:10.1037/e675542012-001 · Cited by 9,663
LeDoux, J. E. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.155 · Cited by 8,444
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Cognitive Therapy of Depression
HOLLON, S. D., & BECK, A. T. (1979) · Cognitive-Behavioral Interventions · doi:10.1016/b978-0-12-404480-7.50012-5 · Cited by 4,685
Bower, G. H. (1981) · American Psychologist · doi:10.1037/0003-066x.36.2.129 · Cited by 4,154 · cited 1×
“Emotional memory is thought to be a particularly important aspect of emotional processing relevant to depression, from both experimental data from depressed patients (see Leppänen, 2006) and theoretical models of depression (e.g. Bower, 1981).”
BackgroundTrivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 2×
“…effective treatments, it is estimated that more than 50% of patients treated for major unipolar depression will not respond to first-line treatment (Trivedi et al., 2006) and that furthermore, up to half of all patients will not reach an adequate therapeutic response even after a treatment switch…”
BackgroundEkman, P. (1993) · American Psychologist · doi:10.1037/0003-066x.48.4.384 · Cited by 3,441
Attentional bias in emotional disorders
MacLeod, C., Mathews, A., & Tata, P. (1986) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.95.1.15 · Cited by 3,152
Self-referential processing in our brain—A meta-analysis of imaging studies on the self
Northoff, G., Heinzel, A., de Greck, M., Bermpohl, F., Dobrowolny, H., & Panksepp, J. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.12.002 · Cited by 2,792
Research works printed but not linked: 9
- Bradley AJ, Lenox-Smith AJ (in press) Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A review of meta-analyses and large randomised pragmatic trials. J Psychopharmacology.
- Deakin JW, 2012, 28th CINP World Congress of Neuropsychopharmacology
- Kuhn R, 1957, Schweiz Med Wochenschr, 87, 1135
- Loomer HP, 1957, Psychiatr Res Rep, 8, 129
- Murrough JW, 2012, Biol Psychiatry
- NICE, 2007, CG22 Anxiety: NICE Guideline (amended)
- Robinson E, 2012, British Association for Psychopharmacology Summer Meeting
- Satel SL, 1989, J Clin Psychiatry, 50, 241
- 10.1037/0033-2909.98.2.219 · DOI · Paper page
Cited by
MDMA enhances emotional empathy and prosocial behavior
Hysek, C. M., Schmid, Y., Simmler, L. D., Domes, G., Heinrichs, M., Eisenegger, C., Preller, K. H., Quednow, B. B., & Liechti, M. E. (2014) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nst161 · Cited by 356
Meta-analysis of emotion recognition deficits in major depressive disorder
Dalili, M. N., Penton-Voak, I. S., Harmer, C. J., & Munafò, M. R. (2015) · Psychological Medicine · doi:10.1017/s0033291714002591 · Cited by 349
“In particular, a wide body of research suggests that antidepressant medication reduces the recognition of, and neural responses to, negative facial expressions in healthy participants and patients with MDD (see Pringle et al. 2013).”
Self-citationPringle, A., & Harmer, C. J. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.4/apringle · Cited by 61
Self-citationMa, H., Cai, M., & Wang, H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.792960 · Cited by 59
“Almost all later discovered antidepressants were developed to act on 5-HT and NA neurotransmitters, with only a few exceptions (44, 45).”
BackgroundEarly effects of duloxetine on emotion recognition in healthy volunteers
Bamford, S., Penton-Voak, I., Pinkney, V., Baldwin, D. S., Munafò, M. R., & Garner, M. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115570085 · Cited by 15
Metadata
- Authors
- Pringle, A., McCabe, C., Cowen, P., & Harmer, C.
- Affiliations
- University of Oxford (GB)
- Department of Psychiatry, University of Oxford, Oxford, UK
- ORCID
- McCabe, C
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2013-02-07
- Volume
- 27
- Issue
- 8
- Pages
- 719-731
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2044852178
- Cited by
- 37
- References
- 144
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 1 · 2017: 2 · 2016: 3 · 2015: 6 · 2014: 4 · 2013: 3
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Update notices
- correction (2013-09-11)
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- antidepressants, serotonin, norepinephrine, emotional processing, major depressive disorder, personalized treatment, negative bias, reward processing, anhedonia, emotional memory, noradrenergic antidepressants, selective serotonin reuptake inhibitors
- MeSH terms
- Animals, Antidepressive Agents, Major Depressive Disorder, Emotions, Humans, Norepinephrine, Serotonin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressant treatment and emotional processing: can we dissociate the roles of serotonin and noradrenaline? https://app.cochat.ai/papers/10.1177/0269881112474523
- The paper
- Pringle, A., McCabe, C., Cowen, P., & Harmer, C. (2013). Antidepressant treatment and emotional processing: can we dissociate the roles of serotonin and noradrenaline? Journal of Psychopharmacology. https://doi.org/10.1177/0269881112474523
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.